Invitae Stock

Invitae Corp: Genetics Stock Reporting Supercharged Revenue Growth

Invitae Corp's Revenue to More Than Double by 2020  Genetic testing has rapidly become the norm in the healthcare field as its cost declines. A small-cap play in this growing space is Invitae Corp (NYSE:NVTA), up 55% this year but down 21% over the past three months. Invitae provides…

Invitae Corp: This Biotech Stock Just Surged 120%, More to Come?

Big Profits on the Way? Today’s chart highlights a company in one of the fastest-growing biotech industries, genetic testing. Also known as DNA testing, genetic testing helps make genetic diagnoses of a person’s vulnerabilities to inherited diseases. There are more than 1,000 genetic tests currently in use and…